53. Sjogren syndrome Clinical trials / Disease details

Clinical trials : 283 / Drugs : 320 - (DrugBank : 101) / Drug target genes : 56 - Drug target pathways : 181

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00543166 (ClinicalTrials.gov)	February 2003	9/10/2007	Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue	Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue	Sjogren's Syndrome	Drug: dehydroepiandrosterone	Helsinki University	Göteborg University;Uppsala University	Active, not recruiting	18 Years	80 Years	Both	107	Phase 4	Finland
2	NCT00391924 (ClinicalTrials.gov)	May 2000	24/10/2006	Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome	Fatigue and General Well-Being in Patients With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome: Effects of Dehydroepiandrosterone Administration	Lupus Erythematosus, Systemic;Sjogren's Syndrome	Drug: Dehydroepiandrosterone	UMC Utrecht	University Medical Centre Groningen;Dutch Arthritis Association	Completed	18 Years	N/A	Female	120	Phase 2	Netherlands
3	NCT00001598 (ClinicalTrials.gov)	May 1997	3/11/1999	DHEA Treatment for Sjogren's Syndrome	Dehydroepiandrosterone (DHEA) Treatment for Sjogren's Syndrome	Lacrimal Apparatus Disease;Salivary Gland Disease;Sjogren's Syndrome;Xerostomia	Drug: Dehydroepiandrosterone	National Institute of Dental and Craniofacial Research (NIDCR)	NULL	Completed	N/A	N/A	Female	28	Phase 2	United States